Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • 2025
  • Page 744
ai-reduces-costs-and-speeds-up-chip-design:-there’s-more-to-the-story
Posted inBiotechnology

AI Reduces Costs and Speeds Up Chip Design: There’s More to the Story

January 6, 2025
Researchers from Princeton Engineering and the Indian Institute of Technology have made a groundbreaking advancement in the design of specialized…
Read More
breakthrough-ai-tool-leverages-routine-blood-tests-to-forecast-immunotherapy-outcomes-across-diverse-cancers
Posted inBiotechnology

Breakthrough AI Tool Leverages Routine Blood Tests to Forecast Immunotherapy Outcomes Across Diverse Cancers

January 6, 2025
In a significant advancement for cancer treatment, researchers have unveiled a groundbreaking model designed to enhance the prediction of patient…
Read More
ancient-rome’s-decline-in-iq-linked-to-widespread-lead-pollution,-new-research-reveals
Posted inBiotechnology

Ancient Rome’s Decline in IQ Linked to Widespread Lead Pollution, New Research Reveals

January 6, 2025
Lead pollution, a significant issue affecting human health, has its roots deep in history, tracing back to the Roman Empire.…
Read More
ai-accelerates-and-expands-drug-development
Posted inGenetics

AI Accelerates and Expands Drug Development

January 6, 2025
The most familiar artificial intelligence (AI) applications include text generation, facial recognition, and autonomous driving. But there are other AI…
Read More
automation-in-cell-line-development-for-biotherapeutics:-current-trends-and-challenges
Posted inGenetics

Automation in Cell Line Development for Biotherapeutics: Current Trends and Challenges

January 6, 2025
Successfully producing large quantities of biotherapeutics, including monoclonal antibodies and recombinant protein products, depends on robust and reliable cell line…
Read More
ketamine-reduces-l-dopa-related-uncontrolled-movements-in-parkinson’s-rat-model
Posted inGenetics

Ketamine Reduces L-DOPA-Related Uncontrolled Movements in Parkinson’s Rat Model

January 6, 2025
University of Arizona researchers have revealed new insights into the neurobiological cause of the involuntary, uncontrollable movement disorders that develop…
Read More
vertex-pays-orna-$65m-to-work-on-next-gen-gene-therapies-for-blood-disorders
Posted inBiotechnology

Vertex pays Orna $65M to work on next-gen gene therapies for blood disorders

January 6, 2025
Vertex Pharmaceuticals is hoping to build upon its existing rare blood disease treatment portfolio, teaming up with Orna Therapeutics’ ReNAgade…
Read More
“suspended-animation”-technique-for-blood-draws-designed-to-aid-research-for-underserved-populations
Posted inGenetics

“Suspended Animation” Technique for Blood Draws Designed to Aid Research for Underserved Populations

January 6, 2025
If a patient or research study volunteer is having a blood draw at or near a research facility that can…
Read More
study-reveals-limited-prescription-of-gender-affirming-medications-for-adolescents-in-the-us
Posted inBiotechnology

Study Reveals Limited Prescription of Gender-Affirming Medications for Adolescents in the US

January 6, 2025
Puberty blockers and gender-affirming hormones have become central topics in discussions about health care for transgender and gender-diverse adolescents in…
Read More
new-insights:-ing5-disrupts-aerobic-glycolysis-in-lung-cancer-cells-through-tie1-driven-phosphorylation-of-pyruvate-dehydrogenase-kinase-1-at-y163
Posted inBiotechnology

New Insights: ING5 Disrupts Aerobic Glycolysis in Lung Cancer Cells Through TIE1-Driven Phosphorylation of Pyruvate Dehydrogenase Kinase 1 at Y163

January 6, 2025
Lung cancer remains one of the most formidable adversaries in the realm of oncological diseases, standing as a leading cause…
Read More

Posts pagination

Previous page 1 … 742 743 744 745 746 … 757 Next page

Privacy Policy    Terms

Scroll to Top